YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway.

YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway. — المؤلف: Tong, Hui — Drug design, development and therapy 20190618

المؤلف
Tong, Hui
النشر
Drug design, development and therapy 20190618
الوصف
317-326 p.
الموضوعات
Antineoplastic Agents, Alkylating؛ Cell Line, Tumor؛ Cell Survival؛ Dose-Response Relationship, Drug؛ Drug Resistance, Neoplasm؛ Glioma؛ Humans؛ Proto-Oncogene Proteins c-mdm2